Previous Article | Next Article ![]()
Molecular and Cellular Biology, January 2007, p. 92-101, Vol. 27, No. 1
0270-7306/07/$08.00+0 doi:10.1128/MCB.01023-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Department of Molecular and Cellular Biology and Howard Hughes Medical Institute, University of Arizona, Tucson, Arizona 85721
Received 7 June 2006/ Returned for modification 11 October 2006/ Accepted 17 October 2006
|
|
|---|
|
|
|---|
To determine if cytoplasmic RNA decay pathways might also function in the degradation of the CUTs and SRG1, we first focused on examining the mechanisms by which the SRG1 RNA is degraded. We found that the SRG1 locus produces two RNAs with different 3' ends (referred to as SRG1-s and SRG1-l), which are both primarily degraded in the cytoplasm by decapping and 5'-to-3' decay in a process independent of nonsense-mediated decay (NMD). In addition, a SRG1-SER3 read-through transcript (referred to as SRG1-rt) is also degraded by cytoplasmic decapping and 5'-to-3' decay, although this RNA is targeted for decapping by NMD. Furthermore, closer investigation of other CUTs shows that a number of them may be degraded by both cytoplasmic and nuclear pathways, and some can enter translation. This supports the idea that different intergenic RNA Pol II transcripts may be processed and degraded by a variety of mechanisms. In addition, these results identify a possible mechanism for the evolution of new protein-encoding genes.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Yeast strains used in this study
|
-32P]dATP-labeled probes or 5'-end [
-32P]ATP- labeled oligonucleotide probes and scanned using a PhosphorImager (Typhoon 9410; Amersham Biosciences). RNase H reactions were performed basically as described previously (9), using 40 µg RNA and 600 ng oligo(dT) per reaction (for Fig. 1B) or 300 µg RNA and 7 µg oligo(dT) per reaction (for Fig. 2C). Products were resolved on 6% polyacrylamide gels, blotted onto a Nytran membrane, and probed with a [
-32P]ATP-labeled SRG1 5'-end-specific oligonucleotide probe (5'-GGTTCTTCCTTTATATACATAAC-3'; oRP 1304) (Fig. 1) or a random-primed SRG1 probe spanning 470 to 125 (relative to SER3 start; using primers oRP 1308 and oRP 1309) (Fig. 2). CUT probes were PCR amplified using the primers NEL025c (F, 5'-CGTACAGTGCAGGTTTTGAC-3'; R, 5'-GCTCGAGACATTTTGGGTAGA-3') (oRP 1310 and oRP 1311) and NMR026w (F, 5'-CAATTTTATCAAGACCGCAC-3'; R, 5'-TAAACGTTAGCGTGTTCTTC-3') (oRP 1312 and oRP 1313) and random-prime labeled. A 5'-end,
-32P-labeled 7s oligonucleotide probe (oRP 100) was used for normalization.
![]() View larger version (24K): [in a new window] |
FIG. 1. Three forms of SRG1 RNA. A. Agarose Northern blot showing that three transcripts are produced from the SRG1 locus. B. RNase H-directed cleavage of SRG1 using oligo(dT). The probe used and the expected sizes of cleavage products following treatment with oligo(dT) are shown in panel C. L, SRG1-l; S, SRG1-s. Positions of the size markers (M) are indicated in nucleotides. This experiment was repeated three times; a representative blot is shown. C. Schematic of SRG1 transcripts, their approximate sizes, and their 3' ends (black octagons) relative to SER3. The SER3 promoter is represented by the gray arrow. The schematic is not to scale.
|
![]() View larger version (36K): [in a new window] |
FIG. 2. Accumulation of SRG1 transcripts in mutant strains. A. Accumulation of SRG1 RNAs in various mutant strains at steady state. The short (S), long (L), and read-through (RT) forms of SRG1 are indicated. 7s is used as a loading control. At least three independent samples per mutant strain were examined; a representative blot is shown. B. Accumulation of SRG1-l and SRG1-s RNAs in various mutant strains. Bars represent the averages of at least three independent experiments, normalized to the 7s loading control. C. RNase H-directed cleavage with (+) or without () oligo(dT) of SRG1 RNA in indicated strains. 7s is used as a loading control. Positions of the size markers (M) are indicated in nucleotides. "S" denotes SRG1-s following cleavage; "C" indicates a constant band which does not change in size. This experiment was repeated three times; a representative blot is shown. D. Accumulation of SRG1-rt RNA in various mutant strains. Bars represent the averages of at least three independent experiments, normalized to the 7s loading control.
|
Analysis of previously published microarray experiments.
Experimental data from previous studies using Affymetrix Yeast S98 arrays (Affymetrix, Santa Clara, CA) were downloaded from http://jacobsonlab.umassmed.edu/publications/2003-Feng/supplementarydata/(NMD(26)-Raw Data-9335.txt) (11) and http://www.ncbi.nih.gov/geo, accession number GSE2579 (28). All probes annotated as "nonannotated serial analysis of gene expression (SAGE) open reading frames (ORFs)" were considered; we used the absent/present spot calling from the primary data set to include only those probes that detected an RNA. Analysis was performed using GeneSpring (Agilent Technologies, Palo Alto, CA) and Microsoft Excel. For the cytoplasmic decay mutant arrays (11), a t test comparison of mutant and wild-type readings for a given target was performed, followed by filtering on confidence for increases in level using the Benjamini and Hochberg false discovery rate adjustment, with a P value cutoff of 0.01. Targets with significant changes in the xrn1
or dcp1
strain or changes in all three NMD mutant strains (upf1
, upf2
, and upf3
strains) compared to wild type were selected. The nuclear arrays were not performed enough times to allow for this type of analysis. Instead, for each target, each rrp6
reading was compared to the mean of the two wild-type values, and the average of the two readings was used to give an rrp6
/WT comparison. Targets with an rrp6
/WT ratio of at least 3 were selected. Next, SAGE ORF coordinates were acquired from Affymetrix and used to annotate the yeast genome viewer gBrowse (http://db.yeastgenome.org/cgi-bin/gbrowse/yeast/). Each SAGE ORF was checked on gBrowse; those overlapping annotated genomic elements were not considered CUTs and not included in the analysis.
|
|
|---|
1,900-bp read-through transcript that continues to the 3' end of the SER3 gene (referred to as SRG1-rt). The SRG1 locus also produces a smaller transcript (20), which we were able to resolve into two transcripts on an agarose Northern blot (Fig. 1A). An RNase H-directed cleavage using an SRG1-specific oligonucleotide and SRG1 3'-end probe showed that these transcripts have different 3' ends (data not shown). To map the positions of the 3' ends, treatment with oligo(dT) and RNase H was used to remove any poly(A) tail and the RNAs were analyzed using a polyacrylamide Northern blot assay (Fig. 1B). This revealed that the smaller band, referred to herein as SRG1-s, corresponds to a 3' end approximately 400 nucleotides downstream of the initiation site (Fig. 1B, "S"). Further, since this smaller SRG1 RNA becomes approximately 60 nucleotides smaller following RNase H treatment with oligo(dT), it is apparently polyadenylated (Fig. 1B). The larger SRG1 band on the agarose Northern blot corresponds to a set of closely spaced 3' ends (referred to collectively as SRG1-l) located approximately 480 to 520 nucleotides from the initiation site (Fig. 1B, "L") which also appear to be polyadenylated (Fig. 1B). Our finding that the SRG1 RNAs can be polyadenylated agrees with previous work that showed enrichment of SRG1 in a poly(A)+ RNA fraction (20), although a second group did not observe a strong enrichment of SRG1 following oligo(dT) selection of poly(A)+ RNA (8). Therefore, to further confirm that SRG1 RNAs are polyadenylated, we performed 3' rapid amplification of cDNA ends and were successful in amplifying both SRG1-s and SRG1-l, suggesting that at least some fraction of SRG1 is indeed polyadenylated (data not shown). In conclusion, the SRG1-s and SRG1-l RNAs are a mixture of polyadenylated molecules with different 3' ends, all of which map within the SER3 promoter or coding region (Fig. 1C).
SRG1-s and SRG1-l accumulate in mutant strains defective for cytoplasmic decapping or 5'-to-3' exonuclease activity.
To determine how the SRG1 transcripts are degraded, we first examined the steady-state accumulation of the SRG1-s and SRG1-l RNAs in strains with defects in various nuclear and cytoplasmic RNA decay mechanisms. We saw at least a fivefold accumulation of both the SRG1-s and SRG1-l transcripts in an xrn1
strain, which lacks the major cytoplasmic 5'-to-3' exonuclease, as well as three- to fivefold accumulation in the dcp1
and dcp2
decapping mutant strains (Fig. 2A and B). These observations suggest that the SRG1-s and SRG1-l RNAs can be exported and degraded in the cytoplasm by decapping and 5'-to-3' degradation. Consistent with this possibility, both SRG1-s and SRG1-l also accumulated in a dhh1
strain, which is defective in mRNA decapping (Fig. 2A and B) (7). SRG1-s and SRG1-l are unlikely to be degraded by the cytoplasmic exosome, as they do not accumulate in the ski2
, ski4-1, and ski7
exosome mutant strains (Fig. 2A and B; also data not shown) (2, 25).
Although the SRG1-s and SRG1-l RNAs lack a long ORF, they do contain very small potential reading frames of 9 to 22 codons, which suggested that the SRG1 RNAs could be targets of the NMD pathway (reviewed in reference 3). However, the levels of SRG1-s and SRG1-l are similar in upf1
, upf2
, and upf3
strains compared to wild type (Fig. 2A and B and data not shown). Since Upf1p, Upf2p, and Upf3p are required for NMD, this suggests that these short SRG1 RNAs are not targets of NMD. SRG1-s and SRG1-l also do not accumulate in the pop2
, ccr4
, pan2
, and ccr4
pan2
deadenylation mutant strains (data not shown), suggesting that the decay of SRG1-s and SRG1-l RNAs is independent of deadenylation. Taken together, the above observations argue that both the SRG1-s and SRG1-l RNAs can be exported to the cytoplasm and degraded by deadenylation-independent decapping, followed by 5'-to-3' exonuclease digestion by Xrn1p.
To examine whether SRG1 transcripts could also be degraded in the nucleus, we examined the accumulation of the SRG1-s and SRG1-l transcripts in a strain defective for Trf4p, a nuclear poly(A) polymerase that can adenylate substrates and target them for degradation by the nuclear exosome, or Rrp6p, a 3'-to-5' exonuclease associated with the nuclear exosome (Fig. 2A and B) (14, 17, 18, 24, 28). The SRG1-s RNA did not significantly accumulate in the rrp6
or trf4
strain (Fig. 2A and B). In contrast, the SRG1-l RNAs accumulated approximately fourfold over wild-type levels in both the rrp6
and trf4
strains (Fig. 2A and B) (8). Moreover, a comparison of the sizes of the SRG1-l transcripts with and without removal of their poly(A) tails by oligo(dT) treatment indicated that the transcripts were hyperadenylated in the rrp6
strain but not in the trf4
strain (Fig. 2C). These observations are similar to what has been seen for CUTs that are thought to degrade in the nucleus (8, 24, 28), which raises the possibility either that the SRG1-l RNAs are also degraded in the nucleus or that Trf4p or Rrp6p can specifically limit SRG1-l levels by an alternative mechanism (see Discussion).
SRG1 decays more slowly in cytoplasmic decay mutant strains.
The observations that SRG1-s and/or SRG1-l levels increased in strains defective in either nuclear or cytoplasmic RNA decay mechanisms raise three possibilities, which can be distinguished by directly measuring the decay rates of the SRG1 RNAs in various mutant strains. First, SRG1-s and/or SRG1-l could be primarily degraded in the cytoplasm and accumulate in rrp6
and trf4
mutant strains for indirect reasons. In this case, SRG1-s and SRG1-l RNAs should decay more slowly in dcp2
or xrn1
mutant strains but not in rrp6
and trf4
strains. Alternatively, SRG1-s and/or SRG1-l RNAs could be degraded in the nucleus and Xrn1p and Dcp2p could indirectly affect their production. In this case, the SRG1-s and/or SRG1-l RNAs should decay more slowly in rrp6
and trf4
strains but not in the xrn1
and dcp2
strains. Finally, some of the SRG1-s and/or SRG1-l RNAs could be degraded in each compartment, which would predict that they would decay more slowly in xrn1
, dcp2
, rrp6
, and trf4
mutant strains. To distinguish between these possibilities, we utilized a temperature-sensitive allele of RNA Pol II (rpb1-1) to measure the decay rates of SRG1-s and SRG1-l in the various mutant strains (Fig. 3).
![]() View larger version (41K): [in a new window] |
FIG. 3. Decay of SRG1 transcripts in mutant strains. A to E. Representative Northern blots showing SRG1 RNA levels in indicated strains following transcriptional shutoff. 7s is used as a loading control. Half-lives indicated are averages calculated from at least three experiments. The half-lives of SRG1-l and SRG1-s (relative to one another) did not significantly differ in any mutant strain tested. F. SRG1-l and SRG1-s decay curves, semilog plot. Curves are calculated from normalized values of at least three experiments per strain. Error bars represent 1 standard deviation from the mean.
|
rpb1-1 or dcp2
rpb1-1 strain, the half-life of both SRG1-s and SRG1-l increased to slightly more than 5 min (Fig. 3B and C). This is consistent with the accumulation data and suggests that at least some fraction of both SRG1-s and SRG1-l is degraded in the cytoplasm through the predominant yeast degradation pathway of decapping followed by 5'-to-3' digestion by the nuclease Xrn1p.
A third, and surprising, observation from measuring decay rates was that both the SRG1-s and SRG1-l RNAs decayed more rapidly in the rrp6
rpb1-1 strain than in the wild-type strain, with a reproducibly shorter half-life of
1 min, a statistically significant difference (P = 0.008 by two-tailed t test) (Fig. 3D). The half-life of both SRG1-s and SRG1-l in a trf4
rpb1-1 mutant strain was intermediate between those in the wild-type and rrp6
rpb1-1 strains (
1.6 min) (Fig. 3E). The increased decay rates of the SRG1-s and SRG1-l RNAs in the rrp6
strain are inconsistent with a model in which these RNAs are primarily substrates for nuclear decay. Based on this fact and the decreased decay rates observed in the xrn1
rpb1-1 and dcp2
rpb1-1 strains, we conclude that the SRG1-s and SRG1-l RNAs are primarily degraded in the cytoplasm by decapping and 5'-to-3' digestion. However, Trf4p and Rrp6p clearly can affect SRG1 RNA accumulation, either by extremely rapid nuclear decay of a subpopulation of these RNAs or by modulation of their transcription (see Discussion).
The SRG1-rt RNA is a substrate for NMD.
To determine how the SRG1-rt transcript is degraded, we also examined its steady-state accumulation in strains defective in various RNA decay mechanisms within both the nucleus and the cytoplasm. The SRG1-rt transcript accumulated in dcp1
, dcp2
, xrn1
, upf1
, upf2
, and upf3
strains (Fig. 2A and D and data not shown). Moreover, the half-life of the SRG1-rt RNA increased in the dcp2
rpb1-1 and xrn1
rpb1-1 strains, from 2.5 min in the wild type to 13.9 and 25 min, respectively (Fig. 3). These results indicate that the read-through RNA can be exported to the cytoplasm, enter translation, and be degraded by NMD. This is consistent with earlier results showing that bicistronic transcripts can be substrates for NMD in yeast (11).
We also observed a higher level of the SRG1-rt RNA in both trf4
and rrp6
strains (Fig. 2A and D). Similarly to the SRG1-l and SRG1-s transcripts, however, the decay rate of SRG1-rt is slightly higher in these strains than in the wild type, with a half-life of 1.8 min in the trf4
rpb1-1 strain and 1.2 min in the rrp6
rpb1-1 strain (Fig. 3). The trend of higher decay rates in these strains, together with the observations suggesting that the SRG1-rt RNA can undergo NMD in the cytoplasm, suggests that the level or processing of the read-through transcript is limited by Rrp6p and Trf4p in a manner yet to be determined (see Discussion).
CUTs are degraded by a variety of pathways.
The observation that SRG1 transcripts can be degraded in the cytoplasm raises the possibility that other intergenic transcripts are also exported from the nucleus and degraded in the cytoplasm. Previous results concluding that CUTs are primarily degraded in the nucleus were largely based on observations that their steady-state expression levels were increased in an rrp6
or trf4
strain compared to wild type (8, 28). Indeed, only in the case of the CUT NEL025c has the loss of Rrp6p been shown to affect the decay rate of the intergenic transcript (28). The possibility that CUTs other than SRG1 may be degraded in the cytoplasm has not been investigated. Given this, we examined how various CUTs are affected by defects in nuclear or cytoplasmic decay mechanisms.
To obtain a general overview of CUT degradation, we utilized Affymetrix microarray data both from the earlier CUT study (28) and from a genome-wide yeast study of xrn1
, dcp1
, and NMD (upf1
, upf2
, and upf3
) mutant strains (11). We began with 14 "canonical CUTs," which accumulated in an rrp6
strain and thus were used as canonical examples in early work (28). Interestingly, three of these CUTsNOR077w, NGR104c, and NHL005calso accumulated significantly in an xrn1
or dcp1
strain (t test with P value cutoff of 0.01; see Materials and Methods), similarly to SRG1 RNAs; two of those three also accumulated in all three NMD mutant strains. These data preliminarily suggested not only that CUTs decay in the nucleus but also that some may be exported to the cytoplasm, enter translation, and be degraded by decapping followed by 5'-to-3' exonucleolytic digestion.
To more broadly examine how intergenic transcripts might be degraded, we expanded our analysis to include additional RNAs. All of the 14 CUTs investigated above are characterized by Affymetrix array documentation as "nonannotated SAGE ORFs," meaning that the sequence was found during a genome-wide serial analysis of a gene expression study (26) but was not associated with a known ORF. Thus, the 1,004 such "SAGE probes" on the array, provided that they were still unannotated, were potentially capable of detecting a pool of "SAGE targets," or candidate CUTs. We eliminated 141 (14%) of the SAGE probes from our analysis because they now recognize annotated genomic features (tRNAs, Ty elements, sn/snoRNAs, or newly recognized ORFs).
To examine whether SAGE targets or candidate CUTs might be decayed within the cytoplasm, we selected SAGE targets whose levels changed significantly (t test with P value cutoff of 0.01; see Materials and Methods) in the xrn1
or dcp1
strain or in all three NMD mutant strains (upf1
, upf2
, and upf3
strains). As the rrp6
arrays were not replicated enough times for this type of analysis, to find candidate CUTs that might be decayed in the nucleus, we selected SAGE targets whose rrp6
/WT signal ratio was at least 3 (see Materials and Methods). In all, these selections identified 207 SAGE targets or candidate CUTs that appeared to accumulate in at least one of the decay mutants.
The microarray data indicate that only 13% (26/207) of the CUTs investigated accumulate solely in the rrp6
strain, suggesting that they are affected predominantly by nuclear processes (Fig. 4). In contrast, 83% of the CUTs accumulated in mutants with defects in cytoplasmic mRNA degradation. Specifically, 45% of the CUTs (93/207) increased only in the dcp1
or xrn1
strain, and 38% (78/207) of the CUTs increased in either the dcp1
or xrn1
strain as well as in all three NMD mutant strains, suggesting that this latter class of RNAs is exported and degraded by NMD. An additional three CUTs increased only in the NMD mutant strains. Note that because NMD requires translation, it implies that these classes of RNAs may be able to enter translation, despite their lack of an annotated ORF. The remaining 3% (7/207) of CUTs accumulated in both the rrp6
strain and one or more cytoplasmic decay mutant strains, suggesting that they may undergo decay in both compartments. Therefore, analysis of these microarray data strongly suggests that intergenic transcripts may be substrates for a variety of decay pathways.
![]() View larger version (19K): [in a new window] |
FIG. 4. Microarray predictions of CUT accumulation. The pie chart shows results for 207 CUTs that showed increased accumulation compared to wild type in the indicated decay mutant strains or strain combinations by microarray analysis.
|
and/or rrp6
strain and examined their levels in xrn1
, rrp6
, and wild-type strains by Northern blot analysis. The results, summarized in Table 2, revealed several interesting observations. First, the majority of the CUTs were undetectable in the wild-type strain, which prevents us from defining a baseline expression level for these CUTs. Second, only two out of nine transcripts predicted to accumulate in an xrn1
strain were detectable by Northern blot analysis in an xrn1
strain (NJL004c and NIR005c). However, both did indeed accumulate to higher levels in the xrn1
strain than in the wild-type strain (Table 2 and data not shown). This demonstrates that some CUTs do accumulate in an xrn1
mutant strain and are therefore likely to undergo cytoplasmic decay. It should be noted that because we were unable to detect the other seven transcripts by Northern blotting in either the wild-type or the xrn1
strain, it is possible that these RNAs do increase in level in the xrn1
strain but remain at very low levels. |
View this table: [in a new window] |
TABLE 2. Array and Northern blot analyses of CUTs
|
strain did so (Table 2). In addition, several of the CUTs (e.g., NIR005c, NML002w, NKL014w, NLR029w, and NKL034c) were detectable by Northern blot analysis at higher levels in the rrp6
strain than in the wild type (Table 2 and data not shown), although on the microarrays they showed either modest or no accumulation in an rrp6
strain. These observations verify the idea that a significant number of CUTs increase in levels in an rrp6
mutant strain and further suggest that microarray analysis may underestimate the number of transcripts affected by Rrp6p.
Decay rate measurements suggest that CUTs are not always highly unstable.
The results of the above analyses strongly suggested that CUTs are degraded by a variety of pathways. However, microarrays measure only the steady-state level of target RNAs, leaving open the possibility that indirect effects may affect CUT accumulation. Therefore, we again used the rpb1-1 mutant and Northern blot analysis to directly measure the decay rate of two CUTs predicted by array analysis to accumulate in the xrn1
and/or the rrp6
mutant strain (Fig. 5). The first, NEL025c, accumulated
25-fold in an rrp6
strain by microarray measurement (Table 2) (28). We found that NEL025c, while expressed at fairly low levels in the rpb1-1 (wild-type) and xrn1
rpb1-1 strains (Fig. 5A), was surprisingly stable, with a half-life of
29 min in the wild-type strain (Fig. 5A). In the rrp6
rpb1-1 strain, NEL025c accumulated to higher levels than in the wild type, yet its half-life was shorter than in the wild type (
10 min). Therefore, our results are consistent with the previously reported accumulation of NEL025c in an rrp6
strain (28), but we do not observe the reported stabilization of NEL025c in the rrp6
strain. While the basis for this discrepancy is unclear, it could be due to the use of quantitative reverse transcription-PCR to detect the RNA in the earlier study (28), which measures the levels of a specific piece of the RNA, versus our use of Northern blot assays, which measure the levels of the full-length transcript.
![]() View larger version (37K): [in a new window] |
FIG. 5. Accumulation and decay of CUTs in the rrp6 or xrn1 mutant strain. A. Representative Northern blots showing NEL025c RNA levels in rpb1-1 (wild-type), rrp6 rpb1-1, and xrn1 rpb1-1 strains following transcriptional shutoff. 7s is used as a loading control. Decay in xrn1 rpb1-1 was not determined precisely, due to a low signal-to-noise ratio. B. The experiment was done as described for panel A but with a probe for NMR026w. Equal exposures of blot sets are shown to facilitate comparison of relative accumulation. Three independent samples from each mutant strain were analyzed; representative examples are shown.
|
strain and to accumulate nearly twofold in an xrn1
strain and at least fourfold in the rrp6
strain (Table 2). Northern blot analysis indicates that this CUT also appears to be fairly stable, as its half-life in the rpb1-1 (wild-type) strain was
21 min (Fig. 5B). It accumulates in the xrn1
rpb1-1 strain. However, while the transcript may increase in size slightly in the rrp6
rpb1-1 strain, it does not accumulate, contradicting the array data (Fig. 5B; Table 2). The half-life of NMR026w does not change significantly in the rrp6
rpb1-1 strain compared to wild type (
20 min) but does increase slightly in the xrn1
rpb1-1 strain (
28 min), consistent with this RNA being degraded primarily in the cytoplasm. Some CUTs can enter translation. The demonstration that SRG1 RNAs and other CUTs can be degraded in the cytoplasm suggested that these RNAs might be able to enter translation. To test this possibility, we used polysome gradients to determine if these RNAs could be associated with polyribosomes. While both SRG1 and NEL025c were observed only in the RNP portion of the gradient (Fig. 6A and data not shown), NMR026w was observed in polyribosome fractions (Fig. 6A). Moreover, because the NMR026w RNA shifts to the RNP fraction when polysomes are disrupted due to osmotic stress (27) (Fig. 6B; fractions 1 to 5 contain 28% of the NMR026w transcript in A but 51% in B), the presence of this RNA in the polyribosome fractions is due to its association with ribosomes.
![]() View larger version (30K): [in a new window] |
FIG. 6. Polysome analysis of the CUT NMR026w. A. Polysome profile of wild-type cells, with Northern blot of RNA isolated from indicated fractions, probed for NMR026w and SRG1. Twenty-eight percent of NMR026w transcript is present in fractions 1 to 5. B. Polysome profile of wild-type cells treated with 1 M KCl for 30 min to disrupt polysome formation, with Northern blot of RNA isolated from indicated fractions, probed for NMR026w. Fifty-one percent of NMR026w is present in fractions 1 to 5.
|
|
|
|---|
, dhh1
, and xrn1
strains (Fig. 2 and 3). This suggests that the SRG1-s and SRG1-l RNAs can be exported from the nucleus and degraded by cytoplasmic decapping and 5'-to-3' decay. In addition, Northern blot analysis demonstrated that the CUT NMR026w showed an increased steady-state level in an xrn1
strain (Fig. 5B), as well as a slightly lower decay rate (Fig. 5B). Finally, examination of available microarray data identified additional intergenic RNAs that accumulate in an xrn1
strain (Table 2; Fig. 4). Taken together, these results demonstrate that some intergenic transcripts are exported and degraded in the cytoplasm.
Intergenic transcripts can be affected by nuclear RNA turnover pathways.
In addition to being degraded in the cytoplasm, intergenic transcripts can also be affected by nuclear RNA turnover mechanisms. This has been suggested by several groups reporting the accumulation of intergenic RNAs in rrp6
and/or trf4
strains (8, 24, 28). Similarly, we also observed that numerous intergenic RNAs accumulated in rrp6
strains as assessed either by examination of preexisting microarray data sets or by direct Northern blot analysis (Table 2; Fig. 4 and 5). Moreover, the SRG1-l RNAs accumulated in both rrp6
and trf4
strains (Fig. 2), which indicates that despite the cytoplasmic decay of the SRG1-l RNAs, the level of these RNAs is somehow limited by Rrp6p and Trf4p. Interestingly, the level of the SRG1-rt transcript is also limited by Rrp6p and Trf4p, despite this transcript being a potential substrate for NMD (Fig. 2).
The effects of Rrp6p on intergenic transcripts.
An unresolved issue is how Rrp6p and Trf4p limit the production of the SRG1-l and SRG1-rt RNAs and potentially of other intergenic transcripts. The simplest model, based on recent findings and discussions in the literature, is that Trf4p adenylates these RNAs in the nucleus and targets them for Rrp6p-dependent 3'-to-5' degradation by the nuclear exosome (8, 18, 24, 28). However, this model is not supported by our observation that the decay rates of the SRG1-l and SRG1-rt transcripts actually increase in the rrp6
strain (Fig. 3), a finding that suggests that Rrp6p is not rapidly degrading these RNAs but may instead be limiting their exposure to other degradative enzymes. Consistent with this latter possibility, we also observed that the decay rate of the CUT NEL025c increased to some extent in an rrp6
strain (Fig. 5A). Moreover, it has been previously observed that the loss of Rrp6p increases the decay rate of pre-mRNAs that accumulate as lariats and yet are degraded in the cytoplasm (13). These observations indicate that this perplexing contradiction, wherein RNAs accumulate yet have increased decay rates in an rrp6
strain, is not unique to SRG1 transcripts.
Two general types of alternative model might explain how loss of Rrp6p and Trf4p could increase SRG1-l and SRG1-rt levels and yet also increase their observed decay rate. In one model, the SRG1-l RNA is recognized as aberrant and retained at the site of transcription in an Rrp6p-dependent manner. This model is based on previous results showing that aberrant transcripts can be retained at the locus in a manner dependent on the nuclear exosome (12, 15, 19). In this model, the higher decay rate observed in the rrp6
strain would be due to faster release of the transcripts from the locus, resulting in faster nuclear export and cytoplasmic decay. To explain the increased levels of the SRG1-l and SRG1-rt RNAs (Fig. 2), nuclear retention of SRG1 would need to be hypothesized to have a direct or feedback effect on some aspect of transcription, possibly elongation, which normally would limit production of the SRG1-l and SRG1-rt transcripts. Thus, in this model, the loss of Rrp6p or Trf4p relieves a transcriptional block, allowing the production of more SRG1-l and SRG1-rt RNAs. However, a requisite of this model is that any such transcriptional inhibition would have to act after initiation and function only after the RNA polymerase passes the 3'-end site of the SRG1-s RNA, as the level of this transcript is not affected by loss of Rrp6p (Fig. 2).
A second model is that Rrp6p and Trf4p recognize and rapidly degrade a significant percentage of nascent SRG1-l and SRG1-rt transcripts. This model requires several additional features. First, this nuclear degradation must be extremely fast such that we cannot measure its rate at steady state, since the vast majority of the RNAs present in the population at steady state would be escapees from this nuclear decay. Second, this model stipulates that the SRG1-rt transcript is also a substrate for Rrp6p-dependent nuclear decay, despite its having a normal 3'-end processing site. Third, because the decay rates of SRG1 transcripts are accelerated in the rrp6
strain, Rrp6p must still limit the ability of at least some RNAs, SRG1-s transcripts included, to reach the cytoplasm. An alternative possibility is a hybrid model wherein Rrp6p functions to retain RNAs with aberrant 3' ends, which has feedback effects on transcription and targets some of the molecules for nuclear decay, as this could explain all of the observations.
Intergenic RNAs can enter translation: implications for the evolution of new ORFs. Two lines of evidence now suggest that at least some intergenic transcripts can enter translation. First, we observed that a subpopulation of intergenic transcripts accumulated in strains defective in NMD (Fig. 4). Since NMD requires translation, this implies that these intergenic RNAs are entering translation. More directly, we observed that the NMR026w RNA was associated with polyribosomes (Fig. 6). However, because the ORF in NMR026w is not conserved, we do not think that this RNA encodes a genuine protein. Instead, the simplest model is that NMR026w represents a class of intergenic transcripts that, because they are produced by RNA Pol II and are capped and polyadenylated, can fortuitously enter translation at some rate. Thus, some intergenic RNAs can both be exported to the cytoplasm and enter translation, even if they do not encode a functional protein.
The ability of "noncoding" intergenic transcripts to enter translation suggests a possible mechanism whereby new ORFs encoded by bona fide mRNAs might arise (Fig. 7). First, a noncoding intergenic transcript would be produced by RNA Pol II. Note that in many cases fortuitous intergenic transcription might arise simply due to the bidirectional nature of eukaryotic transcriptional enhancers. For example, NEL025c lies head to head with the gene DLD3. Between them are two palindromic transcription factor binding sites, which mediate a response to available nitrogen sources (6, 23). We have shown that NEL025c levels respond to nitrogen source in a manner similar to that of DLD3 (data not shown) (23). Second, these intergenic transcripts would gain a 3' end, either by normal polyadenylation or potentially by other methods for 3'-end generation. Not only would intergenic transcripts that gained a normal poly(A) tail be good substrates for nuclear export, but once exported, the capped and adenylated RNA would be expected to engage the cytoplasmic translation machinery. Intergenic transcripts producing an advantageous polypeptide would then be subjected to natural selection, allowing further evolution into a bona fide mRNA with a functional ORF. Thus, intergenic transcripts may not simply be genomic noise but may also be a factor of adaptive mechanisms requiring variation and selection, thus providing fodder for the evolution of new ORFs.
![]() View larger version (16K): [in a new window] |
FIG. 7. Model for new ORF evolution from intergenic transcripts. Shown is the potential mechanism for the evolution of new protein-encoding ORFs from intergenic transcripts. The process begins with adventitious transcription, followed by gain of a proper 3' end to allow for nuclear export, evolution of a start codon and engagement of the translation machinery, and natural selection of a desirable polypeptide. IT, intergenic transcript.
|
This work was supported by the Howard Hughes Medical Institute and grant GM45443 from the National Institutes of Health.
Published ahead of print on 30 October 2006. ![]()
|
|
|---|
1 transcript promotes mRNA decay in Saccharomyces cerevisiae: a stimulatory role for rare codons. Mol. Cell. Biol. 13:5141-5148.This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»